Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Geography
- THE3206921
- 150 Pages
- January 2019
- Diagnostic and Biotech
The increasing incidence of lifestyle diseases are expected to fuel the market growth during the forecast period. As per World health organization in 2016, 13% of the world population (adults) were obese. According to the "The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation" published in 2016, microbes residing in the human gastrointestinal tract act as an endocrine organ, whose composition and functionality contribute to the development of obesity. However, the strict government guidelines is the major concern in the human microbiome market. The strict government guidelines are intended to hamper the market to an extent. The advancements in science and technology made the scientists excited about the potential and potency of fecal matter and the microbes in it. The cell-based therapies found a novel paradigm in drug development, a regulatory framework that reports safety and bio containment issues should be established to minimize adverse events and environmental release of engineered organisms. In recent years, for drug discovery the microbiota plays an important role in the efficacy of therapeutic compounds. There is a new phenomenon in the globe. It is the human gut microbiome and the role it may play in the future of human health. Recently various reports have indicated that the human gut microbiome may be implicated in health conditions such as obesity, metabolism, diabetes, immunity and autism.
The product segment of the human microbiome market is broadly segmented into food, medical foods, probiotics, prebiotics, drugs, diagnostic devices and supplements. In 2017, the probiotics segment held the largest share of the market, by product. However, the prebiotics is expected to grow at the fastest CAGR during the forecast period owing to growing demand for fiber rich food products is expected to drive the market. Additionally, rising investment in the food & beverage industry for innovation and development of new food products enriched with prebiotics.
The application segment of the human microbiome market is broadly segmented into diagnostics and therapeutics. In 2017, therapeutics segment held the largest share of the market, by application. Moreover, the therapeutics segment is expected to grow at the fastest rate during the coming years owing to the increase in digestive problems, increase in the drug-related side effects, and development of therapies for chronic diseases like cancer.
Some of the major primary and secondary sources included in the report for the human microbiome market are National Cancer Institute, National Health Service, World Health Organization, Food and Drug Administration, Public Health England, and Health Protection Agency among others.
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. HUMAN MICROBIOME MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Human Microbiome Market - By Product
3.2.2. Human Microbiome Market - By Disease
3.2.3. Human Microbiome Market - By Application
3.2.4. Human Microbiome Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. HUMAN MICROBIOME MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. CLINICAL TRIALS
4.5. IMPACT ANALYSIS
5. HUMAN MICROBIOME MARKET - GLOBAL ANALYSIS
5.1. GLOBAL HUMAN MICROBIOME MARKET OVERVIEW
5.2. GLOBAL HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
6. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. FOODS MARKET
6.3.1. Overview
6.3.2. Foods Market Revenue Forecasts and Analysis (US$ Mn)
6.4. MEDICAL FOODS MARKET
6.4.1. Overview
6.4.2. Medical Foods Market Revenue Forecasts and Analysis (US$ Mn)
6.5. PROBIOTICS MARKET
6.5.1. Overview
6.5.2. Probiotics Market Revenue Forecasts and Analysis (US$ Mn)
6.6. PREBIOTICS MARKET
6.6.1. Overview
6.6.2. Prebiotics Market Revenue Forecasts and Analysis (US$ Mn)
6.7. DRUGS MARKET
6.7.1. Overview
6.7.2. Drugs Market Revenue Forecasts and Analysis (US$ Mn)
6.8. DIAGNOSTIC DEVICES MARKET
6.8.1. Overview
6.8.2. Diagnostic Devices Market Revenue Forecasts and Analysis (US$ Mn)
6.9. OTHER PROBIOTIC SUPPLEMENTS MARKET
6.9.1. Overview
6.9.2. Other Probiotic Supplements Market Revenue Forecasts and Analysis (US$ Mn)
7. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY DISEASE
7.1. OVERVIEW
7.2. DISEASE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. DIABETES MARKET
7.3.1. Overview
7.3.2. Diabetes Market Revenue Forecasts and Analysis (US$ Mn)
7.4. CANCER MARKET
7.4.1. Overview
7.4.2. Cancer Market Revenue Forecasts and Analysis (US$ Mn)
7.5. AUTOIMMUNE DISORDERS MARKET
7.5.1. Overview
7.5.2. Autoimmune Disorders Market Revenue Forecasts and Analysis (US$ Mn)
7.6. OBESITY MARKET
7.6.1. Overview
7.6.2. Obesity Market Revenue Forecasts and Analysis (US$ Mn
7.7. MENTAL DISORDERS MARKET
7.7.1. Overview
7.7.2. Mental Disorders Market Revenue Forecasts and Analysis (US$ Mn
7.8. OTHER DISEASES MARKET
7.8.1. Overview
7.8.2. Other Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. DIAGNOSTICS MARKET
8.3.1. Overview
8.3.2. Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
8.4. THERAPEUTICS MARKET
8.4.1. Overview
8.4.2. Therapeutics Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
9.1. NORTH AMERICA HUMAN MICROBIOME MARKET OVERVIEW
9.2. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
9.4. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
9.5. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.6. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.2. US Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
9.7.3. US Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.2. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
9.8.3. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.9.2. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
9.9.3. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. EUROPE HUMAN MICROBIOME MARKET OVERVIEW
10.2. EUROPE HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.4. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
10.5. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.6. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. UK MARKET OVERVIEW
10.7.1. UK Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.2. UK Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.7.3. UK Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.2. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.8.3. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.9.2. France Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.9.3. France Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn
11. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC HUMAN MICROBIOME MARKET OVERVIEW
11.2. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.4. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
11.5. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.6. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. JAPAN MARKET OVERVIEW
11.7.1. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.2. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.7.3. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8. CHINA MARKET OVERVIEW
11.8.1. China Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.2. China Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.8.3. China Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9. INDIA MARKET OVERVIEW
11.9.1. India Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.9.2. India Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.9.3. India Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.4. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
12.5. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.6. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. SOUTH AFRICA MARKET OVERVIEW
12.7.1. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.7.2. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.7.3. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8. SAUDI ARABIA MARKET OVERVIEW
12.8.1. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.8.2. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.8.3. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9. UAE MARKET OVERVIEW
12.9.1. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.9.2. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.9.3. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.6. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.7.2. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
13.7.3. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. HUMAN MICROBIOME MARKET, KEY COMPANY PROFILES
15.1. ENTEROME
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. MERCK & CO., INC.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. MICROBIOME THERAPEUTICS, LLC
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. REBIOTIX INC.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. YAKULT HONSHA CO., LTD.
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. OSEL INC.
15.6.1. Business Description
15.6.2. Financial Overview
15.6.3. Product Portfolio
15.6.4. Product Pipeline
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. Vedanta Biosciences, Inc.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. Metabiomics Corporate
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. Synthetic Biologics, Inc.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. DUPONT
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
